Back
Biogen, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Sell
50
BIIB
Biogen, Inc.
Last Price:
$176.48
Seasonality Move:
8.72%
Sell
45
NKTR
Nektar Therapeutics
Last Price:
$43.88
Seasonality Move:
6.44%
Sell
50
Biogen, Inc. (BIIB)
is a Sell
Is Biogen, Inc. a Buy, Sell or Hold?
-
The current Biogen, Inc. [BIIB] share price is $174.82. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $44.46. The Score for NKTR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
What is Biogen, Inc.'s stock price today?
-
The Biogen, Inc. share price today is $174.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $44.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.05 | Buy |
| Relative Strength Index (14 RSI): | 54.84 | Buy |
| Chaikin Money Flow: | 502428 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (171.45 - 180.47) | Sell |
| Bollinger Bands (100): | (136.37 - 168.21) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.56 | Sell |
| Relative Strength Index (14 RSI): | 37.11 | Sell |
| Chaikin Money Flow: | 657085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.71 - 61.11) | Sell |
| Bollinger Bands (100): | (35.93 - 62.65) | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 173.46 | Buy |
| 20-day SMA: | 177.1 | Sell |
| 50-day SMA: | 164.12 | Buy |
| 200-day SMA: | 140.31 | Buy |
| 8-day EMA: | 174.19 | Buy |
| 20-day EMA: | 173.65 | Buy |
| 50-day EMA: | 166.11 | Buy |
| 200-day EMA: | 152.66 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.67 | Sell |
| 20-day SMA: | 54.26 | Sell |
| 50-day SMA: | 56.89 | Sell |
| 200-day SMA: | 31.84 | Buy |
| 8-day EMA: | 47.39 | Sell |
| 20-day EMA: | 51.76 | Sell |
| 50-day EMA: | 53.5 | Sell |
| 200-day EMA: | 38.45 | Buy |
Biogen, Inc. Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.17 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
Biogen, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||